Atlas Trials

Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance

Clinical trial NCT00445796 · COMPLETED

Trial details

NCT number
NCT00445796
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Malaria
Start date
2005-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.